Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Arthritis in United States

296 results

Sort By:

MAD Study of IA-14069

Study ID: NCT05533372
Start Date: 2022-10-10
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

75

Intervention / Treatment

IA-14069

Placebo

Methotrexate

Methotrexate

Sponsor

Elab Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis

Study ID: NCT06383585
Start Date: 2024-12-05
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

oZTEo

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Study ID: NCT06671496
Start Date: 2025-03-10
End Date: 2028-01-26
Study Type

Interventional

Study Phase

Phase3

No. of Participants

600

Intervention / Treatment

Zasocitinib

Placebo

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

Study ID: NCT03297775
Start Date: 2017-06-22
End Date: 2027-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

750

Intervention / Treatment
Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Non-invasive Evaluation of Upper and Lower Body Function With Showmotion

Study ID: NCT04137835
Start Date: 2021-06-01
End Date: 2025-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Showmotion

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Study ID: NCT03414502
Start Date: 2007-12-10
End Date: 2029-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

Methotrexate

Abatacept

Adalimumab

Azathioprine

Baricitinib

Certolizumab

Etanercept

Golimumab

Hydroxychloroquine

Infliximab

Leflunomide

Minocycline

Rituximab

Selfish

Sulfasalazine

Tofacitinib

Sponsor

University of Nebraska

Source: clinicaltrials.gov

Share:
Add to list

Embo Registry; National Registry for Artery Embolization

Study ID: NCT06477965
Start Date: 2024-07-15
End Date: 2029-07-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Artery Embolization

Sponsor

Vascular Solutions of North Carolina

Source: clinicaltrials.gov

Share:
Add to list

FX Shoulder Prospective Clinical Study

Study ID: NCT06078865
Start Date: 2021-03-31
End Date: 2031-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

FX Artificial Shoulder Prosthesis

Sponsor

FX Shoulder Solutions

Source: clinicaltrials.gov

Share:
Add to list

AETOS Shoulder System

Study ID: NCT06319911
Start Date: 2024-03-05
End Date: 2030-08-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

220

Intervention / Treatment

Eagle

Sponsor

Smith & Nephew, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Study ID: NCT05669833
Start Date: 2023-07-14
End Date: 2026-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

63

Intervention / Treatment

Guselkumab

Golimumab

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list